Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery.

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Pharmacology

Background:

• Polymeric carriers are common for controlled drug delivery, especially for corticosteroids in inflammatory diseases.
• Existing polymer-based systems face challenges like low drug loading, inconsistent release, and inflammation.
• Novel approaches are needed to improve corticosteroid delivery systems.

Purpose of the Study:

• To investigate corticosteroid dimers as a polymer-free platform for controlled drug delivery implants.
• To evaluate the fabrication, erosion, and drug release characteristics of these dimer implants.
• To assess the in vivo efficacy and pharmacokinetics of corticosteroid dimer implants.

Main Methods:

• Low molecular weight corticosteroid dimers were processed into implant materials using standard fabrication techniques.
• Implants were characterized for surface erosion and in vitro drug release kinetics.
• In vivo studies involved ocular implantation in rats and intravitreal implantation in rabbits to assess anti-inflammatory effects and pharmacokinetics.

Main Results:

• Corticosteroid dimer implants demonstrated surface erosion, enabling controlled and reproducible in vitro drug release.
• Dexamethasone dimer ocular implants effectively reduced lipopolysaccharide-induced inflammation in rats.
• Intravitreal dexamethasone dimer implants in rabbits showed predictable pharmacokinetics and extended drug release (>6 months) compared to commercial polymeric implants.

Conclusions:

• Low molecular weight corticosteroid dimers can be fabricated into polymer-free drug delivery implants.
• These implants offer controlled surface erosion and predictable drug release kinetics.
• Corticosteroid dimer implants present a promising alternative to polymeric systems for sustained and effective anti-inflammatory therapy.